Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2023-10-10

Clinical Trial Update: Multimechanistic Treatment Over Time of Migraine Symptoms (MOVEMENT) [Phase 3]

View source ↗

Summary

Phase 3 clinical trial update for MOVEMENT study evaluating a multimechanistic treatment for migraines; results posted after completion.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Axsome Therapeutics, Inc. | Conditions: Migraine | Phase 3 | Status: COMPLETED | Results posted: 2023-10-10